Toggle light / dark theme

Meet 10 Women Who Are Leading The Synthetic Biology Revolution

In the last decade, we have witnessed biology bring us some incredible products and technologies: from mushroom-based packaging to animal-free hotdogs and mRNA vaccines that helped curb a global pandemic. The power of synthetic biology to transform our world cannot be overstated: this industry is projected to contribute to as much as a third of the global economic output by 2030, or nearly $30 trillion, and could impact almost every area of our lives, from the food we eat to the medicine we put in our bodies.

The leaders of this unstoppable bio revolution – many of whom you can meet at the SynBioBeta conference in Oakland, CA, on May 23–25 – are bringing the future closer every day through their ambitious vision, long-range strategy, and proactive oversight. These ten powerful women are shaping our world as company leaders, biosecurity experts, policymakers, and philanthropists focused on charting a new course to a more sustainable, equitable, clean, and safe future.

As an early pioneer in the high-throughput synthesis and sequencing of DNA, Emily Leproust has dedicated her life to democratizing gene synthesis to catapult the growth of synthetic biology applications from medicine, food, agriculture, and industrial chemicals to DNA data storage. She was one of the co-founders of Twist Bioscience in 2013 and is still leading the expanding company as CEO. To say that Twist’s silicon platform was a game-changer for the industry is an understatement. And it is no surprise that Leproust was recently honored with the BIO Rosalind Franklin Award for her work in the biobased economy and biotech innovation.

Clockwork Orange (1971): Ludovico technique

We have what cures you.


#dystopia #technocracy #AClockworkOrange.

A Clockwork Orange is a 1971 dystopian crime film adapted, produced, and directed by Stanley Kubrick, based on Anthony Burgess’s 1962 novel of the same name. It employs disturbing, violent images to comment on psychiatry, juvenile delinquency, youth gangs, and other social, political, and economic subjects in a dystopian near-future Britain.

Study explores the extent of Western dependency on Russian nuclear energy

Russia’s invasion of Ukraine in February 2022 had a profound deep impact on the economy, inflating the prices of energy and food, with detrimental consequences for both individuals and companies worldwide. As a result, many governments, particularly in Europe, have been discussing the possibility of reducing their dependence on Russian energy.

Most of these ongoing discussions specifically focus on fossil fuel energy, leading to the gradual introduction of sanctions for purchasing Russian coal, oil, and gas. However, Russia is also a key global provider of nuclear power, particularly via a state-owned corporation called Rosatom.

Researchers at the Norwegian Institute of International Affairs (NUPI) have recently carried out a study investigating the activity and global portfolio of Rosatom and its subsidiaries. Their findings, published in Nature Energy, highlight the high degree of European dependency on nuclear energy produced by this company, raising important questions about the need to find alternative energy suppliers.

Generative AI set to affect 300 million jobs across major economies

The latest breakthroughs in artificial intelligence could lead to the automation of a quarter of the work done in the US and eurozone, according to research by Goldman Sachs.

The investment bank said on Monday that “generative” AI systems such as ChatGPT, which can create content that is indistinguishable from human output, could spark a productivity boom that would eventually raise annual global gross domestic product by 7 percent over a 10-year period.

But if the technology lived up to its promise, it would also bring “significant disruption” to the labor market, exposing the equivalent of 300 million full-time workers across big economies to automation, according to Joseph Briggs and Devesh Kodnani, the paper’s authors. Lawyers and administrative staff would be among those at greatest risk of becoming redundant.

What If EVE Online Becomes Our Future?

Play EVE Online: https://eve.online/Ridddle_EN

In this video, we explore the fascinating prospects of humanity becoming a proper interstellar civilization, up to Type III on the Kardashev scale. However, this transition process presents our species with a bunch of physical limitations, as well as societal and even biological implications. Many of them are quite unwanted or even ugly! We explore this vast topic by using the latest scientific models as well as the best science fiction worlds from books, TV shows, and even games. Speaking of which, to help us visualize this space-faring future with much-needed scale and fidelity, we turned to CCP Games — the creators of the massively multiplayer online game EVE Online. https://eve.online/Ridddle_EN. It is set in a rich sci-fi universe, where players can create their own character and explore a vast and complex virtual world built according to the well-thought set of consistent in-world rules The game is known for its intricate economy, politics, and warfare mechanics, where players can engage in a variety of activities, including mining resources, trading, building structures, and participating in battles. Quite frankly, the game feels like a real simulation of all those future endeavors humanity will face on the way to becoming a true interstellar species!

Dr. John-Arne Røttingen, MD, PhD — Ambassador for Global Health, Ministry of Foreign Affairs, Norway

Ambassador Dr. John-Arne Røttingen, MD, Ph.D. (https://www.bsg.ox.ac.uk/people/john-arne-rottingen) is Ambassador for Global Health, at the Ministry of Foreign Affairs, Norway, and a Visiting Fellow of Practice, at the Blavatnik School of Government, Oxford University.

Ambassador Dr. Røttingen has previously served as the Chief Executive of the Research Council of Norway; the founding Chief Executive Officer of the Coalition for Epidemic Preparedness Innovations (CEPI); Executive Director of Infection Control and Environmental Health at the Norwegian Institute of Public Health; founding Chief Executive of the Norwegian Knowledge Centre for the Health Services; Professor of Health Policy at the Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo; and Adjunct Professor at the Department of Global Health and Population, Harvard T.H. Chan School of Public Health.

From 2020, Ambassador Dr. Røttingen also chaired the Executive Group and the International Steering Committee of the WHO Solidarity trial to compare four untested treatments for hospitalized people with severe COVID-19 illness. In early 2021, he was appointed by the G20 to the High Level Independent Panel (HLIP) on financing the global commons for pandemic preparedness and response. That same year, he was also appointed to the Pandemic Preparedness Partnership (PPP), an expert group chaired to advise the G7 presidency. From mid-2021, he was part of the Access to COVID-19 Tools Accelerator’s Vaccine Manufacturing Working Group.

Ambassador Dr. Røttingen received his MD and Ph.D. from the University of Oslo, an MSc from Oxford University and an MPA from Harvard University.

How can Europe tackle its unfinished tuberculosis business?

In 2015, European countries formulated the Sustainable Development Goals (SDG), which aimed to end TB by 2030. However, in September 2018, global leaders at the first United Nations (UN) General Assembly High-Level Meeting on the Fight Against TB agreed on an ambitious target of eradicating TB by 2022. They strategized that increased access to TB treatment and preventive measures would help achieve their goal quickly. Another measure adopted to progress the TB eradication goal was increasing the funds related to TB research and services.

An uneven progress regarding TB eradication by 2030 was observed in some European regions by the World Health Organization (WHO). Although the majority of Western European countries were on track for TB elimination, Eastern European and Central Asian countries reported a high number of incidences of drug-resistant (DR) TB.

In the European Union/European Economic Area (EU/EEA), TB prevalence is low. Based on the TB surveillance conducted in Europe, out of 30 countries, 24 reported less than 10 TB cases per 100,000 population in 2021. These countries have been encouraged to maintain this low rate and attain the pre-elimination phase of less than 10 TB cases per million population per year. A recent Eurosurveillance journal editorial discussed the progress in the EU/EEA, between 2018 and 2021, towards achieving the 2030 targets for TB elimination.

Dr. Annie Kritcher, Ph.D. — National Ignition Facility — LLNL — Tapping The Power Of The Stars

Tapping The Power Of The Stars — Dr. Andrea Kritcher Ph.D., Lawrence Livermore National Laboratory, U.S. Department of Energy.


Dr. Andrea (Annie) Kritcher, Ph.D. is a nuclear engineer and physicist who works at the Lawrence Livermore National Laboratory (https://www.llnl.gov/). She is the design lead of the HYBRID-E capsule technology within Lawrence Livermore’s Inertial Confinement Fusion (ICF) program, and is a member of the ICF leadership team and lead designer for shot N210808, at their National Ignition Facility, a recent experiment that heralded a significant step towards a fusion break-even target. She was elected Fellow of the American Physical Society in 2022.

Dr. Kritcher was first employed at Lawrence Livermore as a summer intern in 2004, as an LLNL Lawrence Scholar during her time at UC Berkeley, where she earned a master’s degree and doctorate in nuclear engineering, and as a Lawrence postdoctoral fellow in 2009 following completion of her Ph.D. During her postdoctoral appointment she explored using X-rays to measure the properties of warm and hot dense matter (plasma), and measuring how nuclei interact with dense plasma.

In 2012, Dr. Kritcher became a member of scientific staff and now serves as team lead for integrated implosion modeling and is a group leader within the design physics division at LLNL.

Lawrence Livermore National Laboratory (LLNL) is a federally funded research and development center in Livermore, California, United States. Originally established in 1952, the laboratory now is sponsored by the United States Department of Energy. Its principal responsibility is ensuring the safety, security and reliability of the nation’s nuclear weapons through the application of advanced science, engineering, and technology. The laboratory also applies its special expertise and multidisciplinary capabilities towards preventing the proliferation and use of weapons of mass destruction, bolstering homeland security, and solving other nationally important problems, including energy and environmental needs, scientific research and outreach, and economic competitiveness.

The Impending Collapse of the French Economy

Pensions behave as government mandated ponzi schemes. New contributors are needed to pay for past contributors. But what if there are less and less new contributors and contributions? And what if past generations live longer and longer lives?


Limited time: get 5 free stocks when you sign up to moomoo and deposit $100 and 15 free stocks when you deposit $1,000. Use link https://j.moomoo.com/00iPZo.

France is facing massive protests in response to its recently announced pension reform. While France is the only country facing massive protests for now, almost all developed countries will likely be forced to conduct similar pension reforms in the future as they face rapidly aging populations.

0:00 — 1:50 Intro.
1:51 — 5:03 French pension system.
5:04 — 7:15 The Ponzi scheme.
7:16 — 9:42 Pension crisis.
9:43 — 11:20 Demographic time bomb.
11:21 A warning to us all.

Email us: [email protected].

Shining a light into the ‘black box’ of AI

Researchers from the University of Geneva (UNIGE), the Geneva University Hospitals (HUG), and the National University of Singapore (NUS) have developed a novel method for evaluating the interpretability of artificial intelligence (AI) technologies, opening the door to greater transparency and trust in AI-driven diagnostic and predictive tools. The innovative approach sheds light on the opaque workings of so-called “black box” AI algorithms, helping users understand what influences the results produced by AI and whether the results can be trusted.

This is especially important in situations that have significant impacts on the health and lives of people, such as using AI in . The research carries particular relevance in the context of the forthcoming European Union Artificial Intelligence Act which aims to regulate the development and use of AI within the EU. The findings have recently been published in the journal Nature Machine Intelligence.

Time series data—representing the evolution of information over time—is everywhere: for example in medicine, when recording heart activity with an electrocardiogram (ECG); in the study of earthquakes; tracking weather patterns; or in economics to monitor financial markets. This data can be modeled by AI technologies to build diagnostic or predictive tools.